Abstract
Introduction

42
Middle East respiratory syndrome coronavirus (MERS-CoV) has been detected in >1600 patients 43 with a case-fatality rate of 36%. Although the majority of cases occurs in Saudi Arabia (80%), an outbreak 44 in South Korea sparked by a patient with a travel history in the Middle East highlights the potential of 45
MERS-CoV to transmit via the nosocomial route if no appropriate measures are taken (1). MERS-CoV 46
has an unusual broad host tropism, including humans and dromedary camels. A better understanding of 47 the molecular basis of the host tropism will help determine the restrictions of potential host species, 48 improve the functional design of animal models and the development of medical countermeasures. 49
Several animal models for MERS-CoV have been developed. Non-human primates (NHPs) (2-4) and 50 dromedary camel models (5) are naturally susceptible. In addition, several mouse models have been 51 developed, in which the expression of the human variant of the receptor of MERS-CoV, dipeptidyl 52 peptidase 4 (DPP4), allows for viral replication (6) (7) (8) . No other small animal models have been developed. 53
Therefore, if a treatment is shown to be successful against MERS-CoV in the mouse model, further 54 characterization of the treatment needs to be performed in NHPs, a relatively expensive model with 55 limited accessibility. A second small animal model (such as hamsters with modified DPP4 (9, 10)) to 56 confirm results obtained in the mouse model would ensure that only treatments with high likelihood of 57 succeeding would be investigated in NHPs. 58
Fourteen amino acids (AA) are important in the interaction between blades IV and V of human 59 DPP4 (hDPP4) and the receptor binding domain (RBD) of MERS-CoV spike protein (11, 12) . We 60 previously showed that hamster DPP4 (haDPP4) does not function as a receptor for MERS-CoV. This 61 restriction is caused by five out of 14 interacting AAs which differ between hDPP4 and haDPP4 ( Figure 1) supplemented with 10% fetal bovin serum (FBS), 2 mM L-Glutamine, 50 U/ml penicillin and 50 μg/ml of 75 streptomycin (culture DMEM) and maintained at 37°C in 5% CO 2 . MERS-CoV (strain HCoV-EMC/2012) 76 was propagated on VeroE6 cells using DMEM supplemented with 2% FBS, 2 mM L-Glutamine, 50 U/ml 77 penicillin and 50 μg/ml of streptomycin (complete DMEM). MERS-CoV was titrated by end-point titration in 78 quadruplicate on VeroE6 cells cultured in complete DMEM as follows: cells were inoculated with ten-fold 79 serial dilutions of virus, and scored for cytopathic effect 5 days later. TCID 50 was calculated by the 80 method of . 81
82
Plasmids and transfection of BHK cells 83
Mutagenized DPP4 in expression plasmid pcDNA3.1(+) were generated using the Quickchange 84
Lightning site-directed mutagenesis kit (Agilent). Modified DPP4 sequences were confirmed by Sanger 85 sequencing. Baby hamster kidney cells were transfected with 3 μg pcDNA3.1(+) containing the DPP4 86 genes using 8 μl of Lipofectamine 2000 (Life Technologies). DPP4 expression was confirmed via flow 87 cytometry. 88
89
Flow Cytometry 90
Transfected BHK cells were removed with 5 mM EDTA, resuspended in PBS with 2% FBS and 91 stained at 4°C using α-human DPP4 antibody (R&D, AF1180), followed by staining with FITC-tagged 92 donkey anti-goat antibody (Life technologies, A11055). As a control, samples of cells were stained with 93 secondary antibody only. Only viable cells were selected using 7-amino actinomysin-D (Life 94 Technologies). Samples were collected using a LSRII flow cytometer (BD Biosciences). 10,000 gated 95 events were analyzed for each sample. Data were analyzed using FlowJo software (Treestar) comparing 96 transfected BHK cells against untransfected BHK cells. and one triple mutant were constructed with a backbone of haDPP4 and human AAs at the following 119 positions; E291A and T295I; E291A and T336R; T295I and T336R; or E291A and T295I and T336R. 120
Expression of these mutants on BHK cells did not result in MERS-CoV replication ( Figure 2C) . Finally, the 121 functionality of haDPP4 with four out of five human residues was investigated. Attenuated MERS-CoV 122 replication was measured when cells were expressing fully humanized haDPP4 but for residue 341V or 123 346I ( Figure 2D) . 124
Discussion
126
We show that all of the five interacting residues that differ between hDPP4 and haDPP4 are 127 important in binding of MERS-CoV spike protein. This is in contrast to murine DPP4, where mutagenesis 128 of two out of five (L294A and R336T) interacting residues to human AAs resulted in MERS-CoV 129 replication similar to hDPP4 (~1 log lower) (16). 130
Of the five residues important in haDPP4, 291 and 336 were found to be most critical, followed by 131 residue 295, whereas 341 and 346 were found to be least critical. In hDPP4, residues A291, L294 and 132 I295 form a hydrophobic core with RBD residues, surrounded by a hydrophilic periphery (11). In contrast, 133 haDPP4 contains a hydrophilic residue at position 291 (E) and a neutral residue at position 295 (T), 134 theoretically destroying the hydrophobic pocket. Indeed, residue E291 was found to be abortive in both 135 backbones, whereas residue T295 has a moderate effect on RBD-DPP4 binding. Likewise, residue 295 136 was found to be less important in the binding of murine DPP4 by MERS-CoV RBD (17). 137
HaDPP4 is predicted to contain a glycosylation site at position 336, which is absent in hDPP4 and 138 predicted to interfere with RBD binding (17). This is reflected in the observed lack of viral replication when 139 DPP4 contains the hamster residue at position 336. 140
Finally, hDPP4 V341 and I346 form small hydrophobic patches with RBD residues, which are 141 replaced with L341 and V346 in haDPP4. These residues have very similar properties to the residues in 142 hDPP4 and result in a minimum attenuation. Although residues 341 and 346 have an effect on RBD 143 binding in the background of haDPP4, this is much less critical than the interaction between RBD and 144 residues 291, 295 and 336. 145
We observed a difference in outcome when using haDPP4 or hDPP4 as a backbone when 146 investigating residues 295, 341 and 346; changes that have a negligible effect on hDPP4 and RBD 147 binding can be measured as an attenuation in viral replication when using a haDPP4 background, 148 reflecting suboptimal receptor binding. 149
In order to utilize the hamster as an animal model for MERS-CoV all five AAs involved in the host 150 restriction need to be conferred to the hDPP4 equivalents in order to optimize the interaction between 151 receptor and virus. Adaptation of MERS-CoV to haDPP4 is predicted to be unsuccessful, due to the 152 glycosylation site at position 334-336. Transgenic hamsters are virtually absent from scientific literaturedue to the absence of specific gene targeting tools, utilization of the CRISPR/Cas9 system would allow 154 efficient gene targeting and the generation of a new small animal model (9, 10). 155 
